SCHEMBL25823489

SCHEMBL25823489

CCCC(C(=O)OCc1ccccc1)C(C)(C)CC

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.47
L3MBTL1 Q9Y468 4/20 0.43
MAPK1 P28482 2/20 0.43
TDP1 Q9NUW8 2/20 0.43
CYP3A4 P08684 1/20 0.43
TSHR P16473 1/20 0.43
KMT2A Q03164 2/20 0.42
SLC6A2 P23975 1/20 0.42
SLC6A3 Q01959 1/20 0.42
KDM4E B2RXH2 1/20 0.42
MEN1 O00255 1/20 0.42
MAPT P10636 1/20 0.42
CTSK P43235 1/20 0.42
CA1 P00915 1/20 0.42
CA2 P00918 1/20 0.42
SYK P43405 1/20 0.41
LMNA P02545 2/20 0.41
CTSL P07711 2/20 0.41
CTSS P25774 2/20 0.41
CTSB P07858 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14665028 0.84 ALDH1A1 (0.46) ALDH1A1L3MBTL1MAPK1TDP1CYP3A4
SCHEMBL13283481 0.84 ALDH1A1 (0.46) ALDH1A1L3MBTL1KMT2AMEN1CTSK
SCHEMBL7208161 0.81 ALDH1A1 (0.53) ALDH1A1L3MBTL1MAPK1TDP1CYP3A4
SCHEMBL7212486 0.79 ALDH1A1 (0.50) ALDH1A1L3MBTL1MAPK1TDP1CYP3A4
SCHEMBL19105243 0.78 ALDH1A1 (0.56) ALDH1A1L3MBTL1MAPK1TDP1CYP3A4
SCHEMBL11636918 0.78 CA1 (0.63) ALDH1A1L3MBTL1MAPK1TDP1CYP3A4
SCHEMBL29706700 0.77 ALDH1A1 (0.45) ALDH1A1L3MBTL1MAPK1TDP1CYP3A4
SCHEMBL24168485 0.77 ALDH1A1 (0.38) ALDH1A1L3MBTL1MAPK1KMT2AKDM4E
SCHEMBL20445581 0.76 ALDH1A1 (0.55) ALDH1A1L3MBTL1MAPK1TDP1CYP3A4
SCHEMBL28293889 0.76 ALDH1A1 (0.55) ALDH1A1L3MBTL1MAPK1TDP1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230212136-A1 CURABLE RESIN COMPOSITION, CURED PRODUCT, DIFFRACTIVE OPTICAL ELEMENT, AND MULTILAYER DIFFRACTIVE OPTICAL ELEMENT FUJIFILM CORPORATION (JP) 2023-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230212136-A1 CURABLE RESIN COMPOSITION, CURED PRODUCT, DIFFRACTIVE OPTICAL ELEMENT, AND MULTILAYER DIFFRACTIVE OPTICAL ELEMENT TERB1, RER1, LARP1 ALDH1A1 228/4885L3MBTL1 2710/4885MAPK1 2953/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.